Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2021 ,inter alia, to consider and approve The meeting of the Board of Directors of the Company is scheduled to be held on Friday, 18th day of June, 2021 at the Corporate Office of the Company i.e. UL/8, Upper Floor, Suryarath Complex, Panchwati 1st Lane Ambawadi, Ahmedabad, Gujarat-380 006, inter-alia, to consider and approve the Audited Financial Results and Audit Report thereon as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for quarter and financial year ended 31st March, 2021 and to transact all such other businesses as per the agenda items of the Meeting.

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayKashyap Tele-Medicines Ltd 2CINL29110MH1995PLC085738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: CS PARITOSH TRIVEDI Designation: Company Secretary EmailId: investor.relations@kashyaptele-medicines.com Name of the Chief Financial Officer: Raghav Agrawal Designation: Chief Financial Officer EmailId: investor.relations@kashyaptele-medicines.com Date: 30/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Submission of the updated list of Key Managerial Personnel (KMP) of the Company who are authorised to determine materiality of an event or information and further authorised for the purpose of making disclosures to Stock Exchanges under REGULATION 30(5) of the SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015.

Intimation of non-applicability of Annual Secretarial Compliance Report for the year ended 31st March, 2021.

Submission of Certificate from Practicing Company Secretary pursuant to Regulations 40(9) & 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Half Year ended on 31st March, 2021.

Submission of Compliance Certificate as per Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 duly signed by the Compliance Officer of the Company and the Authorised Representative of the Share Transfer Agent of the Company for the half year ended 31st March, 2021.

Kashyap Tele-Medicines Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Paritosh TrivediDesignation :- Company Secretary and Compliance Officer

Submission of confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2021 received from Registrar and Share Transfer Agent of the Company.

The Board of Directors in their meeting held on 27th February, 2021 commenced at 11:30am and concluded at 12:30 pm has approved the resignation of CS Prerna Kakkar and has approved the appointment of CS Paritosh Trivedi as Company Secretary & Compliance Officer of the Company w.e.f 1st March, 2021